Join the club for FREE to access the whole archive and other member benefits.

Reenie McCarthy

CEO at Stealth BioTherapeutics.

Reenie McCarthy is the Chief Executive Officer and a member of the Board of Stealth BioTherapeutics, a biopharmaceutical company developing investigational therapies to treat mitochondrial dysfunction. Reenie is a 20+ year veteran of the investment team of Morningside, Stealth’s principal investor. Reenie has extensive experience working with numerous private nonclinical and clinical stage companies developing drugs across a broad spectrum of therapeutic areas and providing operational and management oversight to venture-backed technology companies. Reenie has been involved with Stealth since 2009, before stepping into a dedicated leadership role at the company in 2015.

Visit website: https://www.stealthbt.com/our-company/#leadership

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Company Stealth BioTherapeutics - Biopharmaceutical company focused on the discovery and commercialization of novel therapies..

Reenie McCarthy is also referenced in the following:

Event
Longevity Leaders World Congress 2021
04-May-2021 to 07-May-2021

The virtual event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX).

Reenie McCarthy News

Super summary of 3rd Annual Longevity Therapeutics Summit

Lifespan.io (LEAF) - 16-Feb-2021

More and more companies making greater and greater progress - 2021 could be an exciting year

Read more...